R B Stricker

Summary

Affiliation: California Pacific Medical Center
Country: USA

Publications

  1. pmc Borrelia burgdorferi aggrecanase activity: more evidence for persistent infection in Lyme disease
    Raphael B Stricker
    International Lyme and Associated Diseases Society Bethesda, MD, USA
    Front Cell Infect Microbiol 3:40. 2013
  2. pmc The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about the development of clinical practice guidelines
    Lorraine Johnson
    California Lyme Disease Association, Ukiah, CA, USA
    Philos Ethics Humanit Med 5:9. 2010
  3. ncbi request reprint Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin
    Raphael B Stricker
    California Pacific Medical Center, San Francisco, 94108, USA
    Am J Reprod Immunol 54:390-6. 2005
  4. ncbi request reprint Lyme disease: point/counterpoint
    Raphael B Stricker
    California Pacific Medical Center, 450 Sutter Street, Suite 1504, San Francisco, CA 94108, USA
    Expert Rev Anti Infect Ther 3:155-65. 2005
  5. doi request reprint Chronic Lyme disease and the 'Axis of Evil'
    Raphael B Stricker
    International Lyme and Associated Diseases Society, PO Box 341461, Bethesda, MD 20827 21461, USA
    Future Microbiol 3:621-4. 2008
  6. ncbi request reprint Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with lyme disease
    Raphael B Stricker
    International Lyme and Associated Diseases Society, Bethesda, MD, USA
    Clin Infect Dis 45:149-57. 2007
  7. ncbi request reprint Lyme disease diagnosis and treatment: lessons from the AIDS epidemic
    R B Stricker
    International Lyme and Associated Diseases Society, Bethesda, MD, USA
    Minerva Med 101:419-25. 2010
  8. ncbi request reprint The Lyme Wars: time to listen
    Raphael B Stricker
    Department of Medicine, California Pacific Medical Center, 450 Sutter Street, Suite 1504, San Francisco, CA, USA
    Expert Opin Investig Drugs 12:1609-14. 2003
  9. ncbi request reprint Musical hallucinations in patients with Lyme disease
    Raphael B Stricker
    Department of Medicine, California Pacific Medical Center, 450 Sutter Street, Suite 1504, San Francisco, CA 94108, USA
    South Med J 96:711-5. 2003
  10. doi request reprint Complement split products c3a and c4a in chronic lyme disease
    R B Stricker
    International Lyme and Associated Diseases Society, Bethesda, MD, USA
    Scand J Immunol 69:64-9. 2009

Collaborators

Detail Information

Publications42

  1. pmc Borrelia burgdorferi aggrecanase activity: more evidence for persistent infection in Lyme disease
    Raphael B Stricker
    International Lyme and Associated Diseases Society Bethesda, MD, USA
    Front Cell Infect Microbiol 3:40. 2013
    ..Discovery of the spirochetal aggrecanase raises many questions about the pathogenesis of Lyme arthritis and lends support to the concept of persistent B. burgdorferi infection in patients with chronic Lyme disease symptoms. ..
  2. pmc The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about the development of clinical practice guidelines
    Lorraine Johnson
    California Lyme Disease Association, Ukiah, CA, USA
    Philos Ethics Humanit Med 5:9. 2010
    ..The article will also discuss pitfalls in the implementation of the IDSA antitrust settlement that should be avoided in the future...
  3. ncbi request reprint Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin
    Raphael B Stricker
    California Pacific Medical Center, San Francisco, 94108, USA
    Am J Reprod Immunol 54:390-6. 2005
    ..We now report the results of IVIG treatment in a larger group of women with this disorder...
  4. ncbi request reprint Lyme disease: point/counterpoint
    Raphael B Stricker
    California Pacific Medical Center, 450 Sutter Street, Suite 1504, San Francisco, CA 94108, USA
    Expert Rev Anti Infect Ther 3:155-65. 2005
    ..The optimal antibiotic regimen for chronic Lyme disease remains to be determined...
  5. doi request reprint Chronic Lyme disease and the 'Axis of Evil'
    Raphael B Stricker
    International Lyme and Associated Diseases Society, PO Box 341461, Bethesda, MD 20827 21461, USA
    Future Microbiol 3:621-4. 2008
    ..Despite its virulent nature, the 'Axis of Evil' perspective is a useful starting point to resolve the controversy over Lyme disease...
  6. ncbi request reprint Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with lyme disease
    Raphael B Stricker
    International Lyme and Associated Diseases Society, Bethesda, MD, USA
    Clin Infect Dis 45:149-57. 2007
    ....
  7. ncbi request reprint Lyme disease diagnosis and treatment: lessons from the AIDS epidemic
    R B Stricker
    International Lyme and Associated Diseases Society, Bethesda, MD, USA
    Minerva Med 101:419-25. 2010
    ..Resolution of the controversy surrounding Lyme disease should lead to improved diagnosis and treatment modelled on the approach to HIV disease...
  8. ncbi request reprint The Lyme Wars: time to listen
    Raphael B Stricker
    Department of Medicine, California Pacific Medical Center, 450 Sutter Street, Suite 1504, San Francisco, CA, USA
    Expert Opin Investig Drugs 12:1609-14. 2003
    ..The risk and prevention of human transmission of Lyme disease merit further study...
  9. ncbi request reprint Musical hallucinations in patients with Lyme disease
    Raphael B Stricker
    Department of Medicine, California Pacific Medical Center, 450 Sutter Street, Suite 1504, San Francisco, CA 94108, USA
    South Med J 96:711-5. 2003
    ..These auditory hallucinations appear to respond to i.v. antibiotic therapy. Patients with musical hallucinations of unknown cause should be tested for infection with the Lyme disease spirochete...
  10. doi request reprint Complement split products c3a and c4a in chronic lyme disease
    R B Stricker
    International Lyme and Associated Diseases Society, Bethesda, MD, USA
    Scand J Immunol 69:64-9. 2009
    ..C4a appears to be a valuable immunologic marker in patients with persistent symptoms of Lyme disease...
  11. ncbi request reprint Lyme disease: the quest for magic bullets
    Raphael B Stricker
    California Pacific Medical Center, San Francisco, CA 94108, USA
    Chemotherapy 52:53-9. 2006
    ..New strategies for the diagnosis, treatment and prevention of Lyme disease are urgently needed...
  12. ncbi request reprint Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease
    Raphael B Stricker
    California Pacific Medical Center, 450 Sutter Street, Suite 1504, San Francisco, CA 94108, USA
    Ann Agric Environ Med 9:111-3. 2002
    ..This observation represents the longest duration of an immunologic abnormality ever documented in chronic Lyme disease. The CD57 lymphocyte subset appears to be a useful marker of longterm infection with the Lyme disease spirochete...
  13. ncbi request reprint Decreased CD57 lymphocyte subset in patients with chronic Lyme disease
    R B Stricker
    Department of Medicine, California Pacific Medical Center, 450 Sutter Street, Suite 1504, San Francisco, CA 94108, USA
    Immunol Lett 76:43-8. 2001
    ..Although immunologic abnormalities appear to play a role in this disease, specific immunologic markers of chronic LD have not been identified...
  14. ncbi request reprint Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin
    R B Stricker
    California Pacific Medical Center, San Francisco, California 94108, USA
    Fertil Steril 73:536-40. 2000
    ..Fetal abnormalities were not observed. CONCLUSION(s): Low-dose IVIG therapy is beneficial for older women with immunologic abortion. The optimum duration of IVIG treatment in these women requires further study...
  15. ncbi request reprint Safety of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease
    R B Stricker
    Union Square Medical Associates, San Francisco, CA, USA
    Minerva Med 101:1-7. 2010
    ..The goal of our study was to evaluate the safety of extended intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease...
  16. doi request reprint Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process
    L Johnson
    California Lyme Disease Association, Ukiah, California, USA
    J Med Ethics 35:283-8. 2009
    ..The implications of the first-ever antitrust investigation of medical guidelines and the proposed model to remediate the tainted IDSA guidelines process are also discussed...
  17. ncbi request reprint Topical immune modulation (TIM): a novel approach to the immunotherapy of systemic disease
    R B Stricker
    Department of Medicine, California Pacific Medical Center, San Francisco 94108, USA
    Immunol Lett 59:145-50. 1997
    ..The potential use of topical immune modulators in autoimmune disease and vaccine development is also delineated. TIM represents a novel approach to immunotherapy that should have widespread application for immunologic diseases...
  18. doi request reprint Re: Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology
    Raphael B Stricker
    Neurology 70:1719; author reply 1719-20. 2008
  19. doi request reprint Searching for autoimmunity in "antibiotic-refractory" Lyme arthritis
    Raphael B Stricker
    Mol Immunol 45:3023-4. 2008
    ....
  20. doi request reprint Persistent Borrelia burgdorferi infection after treatment with antibiotics and anti-tumor necrosis factor-alpha
    Raphael B Stricker
    J Infect Dis 197:1352-3. 2008
  21. ncbi request reprint Lyme disease without erythema migrans: cause for concern?
    Raphael B Stricker
    Am J Med 115:72-3; author reply 73-4. 2003
  22. ncbi request reprint Coinfection with Borrelia burgdorferi and Babesia microti: bad or worse?
    Raphael B Stricker
    J Infect Dis 193:901-2; author reply 902. 2006
  23. ncbi request reprint Coinfection in patients with lyme disease: how big a risk?
    Raphael B Stricker
    Clin Infect Dis 37:1277-8; author reply 1278-9. 2003
  24. ncbi request reprint Duration of antibiotic therapy for Lyme disease
    Raphael B Stricker
    Ann Intern Med 140:W6; author reply W7. 2004
  25. ncbi request reprint Treatment of early Lyme disease
    Raphael B Stricker
    Ann Intern Med 140:577; author reply 577-8. 2004
  26. ncbi request reprint Lyme disease: scratching the surface
    Steven E Phillips
    Lancet 366:1771. 2005
  27. ncbi request reprint Chronic infection in 'post-Lyme borreliosis syndrome'
    Steven E Phillips
    Int J Epidemiol 34:1439-40; author reply 1440-3. 2005
  28. pmc Lyme wars: let's tackle the testing
    Raphael B Stricker
    BMJ 335:1008. 2007
  29. pmc Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF)
    David A Clark
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    J Assist Reprod Genet 23:1-13. 2006
    ..Systematic reviews generating inconclusive results have focused on methodological rigor to the exclusion of biological plausibility...
  30. ncbi request reprint Lyme disease and optic neuritis: long-term follow-up of seropositive patients
    Raphael B Stricker
    Neurology 61:1162; author reply 1162-3. 2003
  31. ncbi request reprint Lyme disease testing
    Steven E Phillips
    Lancet Infect Dis 6:122. 2006
  32. ncbi request reprint Possible role of tick-borne infection in "cat-scratch disease": comment on the article by Giladi et al
    Raphael B Stricker
    Arthritis Rheum 54:2347-8. 2006
  33. ncbi request reprint The mystery of Morgellons disease: infection or delusion?
    Virginia R Savely
    South Austin Family Practice Clinic, Austin, Texas, USA
    Am J Clin Dermatol 7:1-5. 2006
    ..Further clinical and molecular research is needed to unlock the mystery of Morgellons disease...
  34. ncbi request reprint Treatment of Lyme disease: a medicolegal assessment
    Lorraine Johnson
    California Lyme Disease Association, Ukiah, CA 95482, USA
    Expert Rev Anti Infect Ther 2:533-57. 2004
    ..Consideration by healthcare providers of the medicolegal issues outlined in this review will support a more rational approach to the diagnosis and treatment of Lyme disease and related tick-borne illnesses...
  35. ncbi request reprint Re: Prolonged Lyme disease treatment: enough is enough
    Raphael B Stricker
    Neurology 71:1380; author reply 1380-1. 2008
  36. doi request reprint Serologic tests for lyme disease: more smoke and mirrors
    Raphael B Stricker
    Clin Infect Dis 47:1111-2; author reply 1112-3. 2008
  37. ncbi request reprint Inaccurate information about lyme disease on the internet
    Raphael B Stricker
    Pediatr Infect Dis J 24:577-8; author reply 578-9. 2005
  38. ncbi request reprint Rash decisions about southern tick-associated rash illness and Lyme disease
    Steven E Phillips
    Clin Infect Dis 42:306-7; author reply 307-8. 2006
  39. ncbi request reprint Lyme disease: a turning point
    Raphael B Stricker
    Expert Rev Anti Infect Ther 5:759-62. 2007
  40. ncbi request reprint Acute infection with human monocytic ehrlichiosis: the tip of the iceberg?
    Raphael B Stricker
    South Med J 101:214-5. 2008
  41. doi request reprint Reinfection versus relapse in patients with lyme disease: not enough evidence
    Raphael B Stricker
    Clin Infect Dis 46:950; author reply 950-1. 2008
  42. ncbi request reprint Lyme disease controversy: use and misuse of language
    Raphael B Stricker
    Ann Intern Med 137:775-7; author reply 775-7. 2002